Safety data from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 9525-9525 ◽  
Author(s):  
Paul B. Chapman ◽  
Mario Sznol ◽  
Christopher Lao ◽  
Rene Gonzalez ◽  
Gregory A. Daniels ◽  
...  
2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e21058-e21058
Author(s):  
Elisa A. Rozeman ◽  
Yanina Jansen ◽  
MarnixMarnix Heimen Geukes Foppen ◽  
Max Schreuer ◽  
Sofie Wilgenhof ◽  
...  

2013 ◽  
Vol 36 (3) ◽  
pp. 215-222 ◽  
Author(s):  
Sofie Wilgenhof ◽  
Stephanie Du Four ◽  
Frederik Vandenbroucke ◽  
Hendrik Everaert ◽  
Isabelle Salmon ◽  
...  

2012 ◽  
Vol 23 ◽  
pp. ix368 ◽  
Author(s):  
D. Lawrence ◽  
D.F. McDermott ◽  
O. Hamid ◽  
J.S. Weber ◽  
J.D. Wolchok ◽  
...  

2014 ◽  
Vol 13 (9) ◽  
pp. 1165-1173 ◽  
Author(s):  
Daniel Castellano ◽  
Luis M Antón Aparicio ◽  
Emilio Esteban ◽  
Alfredo Sánchez-Hernández ◽  
Jose Ramón Germà ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document